AMN Healthcare Services Inc
AMNNYSECIK 1142750IndustrialsFiscal year ends Dec 31
Reports and events: 272 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0718:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054507 |
| 2026-08-0616:17 ET | 8-K | 9.01 Financial statements and exhibits | 0001142750-26-000008 |
| 2026-05-0818:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032419 |
| 2026-05-0716:20 ET | 8-K | 9.01 Financial statements and exhibits | 0001142750-26-000007 |
| 2026-05-0408:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-054478 |
| 2026-03-1808:00 ET | DEF 14A | Proxy statementPeriod 2026-05-01 | 0001104659-26-029908 |
| 2026-02-2018:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-009918 |
| 2026-02-1916:15 ET | 8-K | 9.01 Financial statements and exhibits | 0001142750-26-000003 |
| 2026-02-0509:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950142-26-000299 |
| 2026-01-1409:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001142750-26-000001 |
| 2025-12-1116:55 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001142750-25-000058 |
| 2025-11-0718:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-050362 |
| 2025-11-0616:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001142750-25-000056 |
| 2025-10-0617:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950142-25-002687 |
| 2025-09-2217:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950142-25-002494 |
| 2025-09-2208:07 ET | 8-K | 7.01 Regulation FD disclosure | 0000950142-25-002481 |
| 2025-08-0818:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001142750-25-000052 |
| 2025-08-0716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001142750-25-000051 |
| 2025-05-0918:13 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001142750-25-000034 |
| 2025-05-0816:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-25-001300 |
| 2025-05-0508:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-044363 |
| 2025-03-1808:01 ET | DEF 14A | Proxy statementPeriod 2025-05-02 | 0001104659-25-024772 |
| 2025-02-2118:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001142750-25-000011 |
| 2025-02-2016:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-25-000463 |
| 2025-02-0716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950142-25-000284 |
| 2024-11-1208:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950142-24-002717 |
| 2024-11-0818:09 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001142750-24-000061 |
| 2024-11-0716:16 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950142-24-002692 |
| 2024-10-0316:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950142-24-002513 |
| 2024-10-0108:23 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950142-24-002477 |
| 2024-08-0918:55 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001142750-24-000050 |
| 2024-08-0816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-24-002148 |
| 2024-07-0916:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950142-24-001871 |
| 2024-05-1018:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001142750-24-000040 |
| 2024-05-0916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-24-001321 |
| 2024-04-2216:16 ET | 8-K | 5.07 Shareholder vote results | 0000950142-24-001169 |
| 2024-03-0508:02 ET | DEF 14A | Proxy statementPeriod 2024-04-19 | 0001308179-24-000058 |
| 2024-02-2216:53 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001142750-24-000016 |
| 2024-02-2116:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950142-24-000504 |
| 2024-02-1516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-24-000460 |
| 2023-11-0619:58 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001142750-23-000030 |
| 2023-11-0216:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-23-002714 |
| 2023-10-2308:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950142-23-002665 |
| 2023-08-0416:21 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001142750-23-000019 |
| 2023-08-0316:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-23-002141 |
| 2023-07-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950142-23-001975 |
| 2023-05-1916:36 ET | 8-K | 5.07 Shareholder vote results | 0000950142-23-001485 |
| 2023-05-0807:14 ET | 8-K | 8.01 Other events | 0000950142-23-001376 |
| 2023-05-0516:16 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001142750-23-000011 |
| 2023-05-0416:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-23-001351 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.